CAUTION: We have been advised that fraudulent emails with a modified domain name have been sent by a source purporting to be from Aird & Berlis LLP. These communications are not legitimate and are not from Aird & Berlis LLP. Disregard any such emails and do not engage with the sender or the email in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre and by emailing Aird & Berlis LLP at help@airdberlis.com.

Back to all Representative Matters
Oct 10, 2019

MediPharm Labs Closes $38.7 Million Credit Facility with a Leading Canadian Schedule 1 Bank

Aaron Collins

MediPharm Labs Corp. (TSX: LABS) ("MediPharm Labs"), a global leader in cannabis extraction, distillation, purification and cannabinoid isolation, through its wholly-owned subsidiary, MediPharm Labs Inc., closed a credit facility with a prominent Canadian Schedule 1 bank for an aggregate $38.7 million. The credit facility is composed of a revolving term facility, a non-revolving term facility and a non-revolving delayed draw term facility.

The closing of the credit facility required extensive due diligence of the company’s current production site and capabilities, along with a detailed review of its expected revenue growth, liquidity and regulatory compliance.

The credit facility will bear interest at the Bank’s prime lending rate plus a certain per cent per annum dependent upon MediPharm Labs’s debt to EBITDA ratio. The credit facility has a first ranking general security interest in the company’s assets and can be repaid without penalty.

MediPharm Labs plans to use the credit facility to support ongoing capital expenditures at its Canadian and Australian facilities, including ramping up its production capacity to meet demand for new product classes, as well as for domestic and international expansions.

Aird & Berlis represented MediPharm Labs with a team that included Aaron Collins (Banking & Finance) and Randy Hooke (Real Estate).

Related Industries

Related Representative Matters

Representative Matters
Waygar Capital Completes $30 Million Financing Aaron Collins and Jonathan Yantzi Sep 16, 2021 Waygar Capital, as agent for Ninepoint Canadian Senior Debt Fund, completed its $30,000,000 finan... Waygar Capital, as agent for Ninepoint Canadian Senior Debt Fund, completed its $30,000,000 financing of Enterprise Group Inc., a specialized equipment rental and services organization to Canada's energy sector, to fund asset purchases, enhance capital expenditures and diversify acquisition strat...
Representative Matters
Energy+ Closes $55 Million Offering of Unsecured Debentures Jill P. Fraser, Melanie Cole and Meredith McCann Aug 10, 2020 On August 10, 2020, Energy+ Inc. closed a $55 million offering of 2.968% senior unsecured debentu... On August 10, 2020, Energy+ Inc. closed a $55 million offering of 2.968% senior unsecured debentures due August 10, 2060.
Representative Matters
MediPharm Labs Completes $37.8 Million Private Placement Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Aaron Collins Jun 22, 2020 MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cann... MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, recently completed a private placement with an institutional investor for aggregate gross proceeds of $37,822,500.